WO2019106652A1 – June 6, 2019 – CANNABINOIDS COMPOSITIONS AND METHODS

Please complete the required fields.




Inventors :

TOUITOU, Elka - 11/67 Derech Ramataim, 4532311 Hod Hasharon; NATSHEH, Hiba - 7 Nuseibeh St., 9701627 Jerusalem

Owner :

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.

Application Number :

WOIL18051175

Document Number :

WO2019106652A1

Priority Date :

November 29, 2017

Filing Date :

November 4, 2018

Date of Grant/ Publication :

June 6, 2019

Class :

; A61K47 / 10; A61K47 / 24; A61K9 / 107; A61K9 / 00; A61K47 / 44; A61K31 / 352

Abstract

A composition for administration into the nasal cavity, the rectal cavity and the vaginal cavity, wherein the composition is an essentially non-aqueous composition comprising: not less than 25% by weight of one or more cannabinoid(s); from 25% to 55% by weight one or more phospholipid(s); and optionally one or more antioxidant(s).

Claim(s)

1) A composition for administration into a body cavity selected from the group consisting of the nasal cavity, the rectal cavity and the vaginal cavity, wherein the composition is an essentially non-aqueous composition comprising: not less than 25% by weight of one or more cannabinoid ( s ) ; from 25% to 55% by weight one or more phospholipid ( s ) ; and optionally one or more antioxidants.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login